Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

KORANGI-PRODUTOS FARMACÊUTICOS, S.A.

NIF 505322307
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €22,490 20 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €22,490 20 contracts
A2 · Late Publication €6,804,123,781 635 contracts
Contract published to BASE more than 10 days after the signing date
LOW €6,804,123,781 635 contracts
A5 · Threshold Splitting €1,140,863 18 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €1,140,863 18 contracts
A6 · Low Competition €2,350 1 contracts
Only one bidder participated in a competitive procedure
MEDIUM €2,350 1 contracts
A9 · Abnormal Price Reduction €8,766,988,972 452 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €8,766,988,972 452 contracts
B5 · Benford's Law Deviation €630,460,246 2 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM €630,460,246 2 contracts
C3 · Missing Mandatory Fields €134,903 26 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €134,903 26 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

6
€350,253,003
19
€347,959,517
19
€344,169,384
46
€342,971,887
142
€325,293,810
8
€324,247,085
15
€321,713,621
27
€320,816,851
13
€320,510,132
17
€320,162,581
38
€320,039,448
15
€319,978,932
10
€319,139,587
7
€319,075,473
7
€319,058,565
3
€318,959,977
12
€318,780,172
2
€318,761,977
14
€318,623,667
5
€318,182,967
Page 1 of 3 · 60 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction B5 · Benford's Law Deviation C3 · Missing Mandatory Fields

Page 1 of 1 · 18 contracts

Medicamentos
PT · 11371316 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€72,968 2025-04-17
Aquisição de medicação antialérgica, vitaminas e sais minerais e medicamentos usados no tratamento de intoxicações
PT · 10785993 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€143,830 2024-05-15
VÁRIOS MEDICAMENTOS
PT · 10672000 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€74,708 2024-03-12
BEAD20240023 - AQUISIÇÃO DE CORRECTIVOS DAS ALT. HIDROELECTROLÍTICAS - 1º SEMESTRE
PT · 10523497 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€19,068 2024-01-29
Medicamentos Relaxantes Musculares_SPMS_Bianual_2022_2023
PT · 9262005 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€142,857 2022-04-28
Medicamentos analgésicos, antipiréticos e antidepressivos ao abrigo do CPA n.º 2018/044
PT · 9254013 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€143,796 2022-04-11
Medicamentos Anestésicos e Relaxantes Musculares
PT · 9206042 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€71,636 2022-04-08
221000206 - Medicamentos do CPA 2021/44
PT · 9117223 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€4,896 2022-03-16
Vários medicamentos
PT · 8977343 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€74,785 2022-02-17
Q1/2462/2021-Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas
PT · 7816168 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€145,203 2021-08-11
06/02627.11/2021 – Aq. Div. Med. do ap. locomotor
PT · 7761313 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,425 2021-06-15
Aquisição de Medicamentos do Aparelho Locomotor ao abrigo do Acordo Quadro 2018/47
PT · 9262961 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,274 2021-05-20
AQUISIÇÃO DE MEDICAMENTOS DO APARELHO LOCOMOTOR, AO ABRIGO DO ACORDO QUADRO 2018/047 DOS SPMS, EPE
PT · 6852946 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,848 2020-06-16
Aquisição de medicamentos
PT · 8353638 · Concurso público
A5 · Threshold Splitting A2 · Late Publication +1
€72,431 2020-03-25
AQ 11437/2019 - AQUISIÇÃO DE MEDICAMENTOS ANALGÉSICOS, ANTIPIRÉTICOS E ANTIDEPRESSIVOS PARA O HDFF, EPE.
PT · 6623677 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€4,989 2020-03-10
Aquisição de medicamentos
PT · 9335660 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€19,983 2019-07-24
PA Nº 96/SF/HPSJD - Aquisição de bens para os Serviços Farmacêuticos do HPSJD para o ano de 2018
PT · 4993819 · Consulta Prévia
A5 · Threshold Splitting A2 · Late Publication +1
€71,898 2018-06-22
Q1/19/2018 - MEDICAMENTOS ANESTÉSICOS E RELAXANTES MUSCULARES
PT · 4276915 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,268 2018-01-09
Overview
Total Value Won
€8,780,286,417
Contracts Won
868
Score 32200 · CRITICAL RISK
NIF
505322307
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.M. [P-fc72]
    Fiscal Único
    since 2008-09-16
  • M.A. [P-707f]
    Fiscal Único
    since 2008-09-16
  • J.C. [P-7573]
    Sócio
    since 2009-06-30
  • M.A. [P-ba59]
    Sócio
    since 2009-06-30
  • M.A. [P-ba59]
    Gerente
    since 2009-06-30
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned